
Cagrilintide
CAS: 1415456-99-3
Cagrilintide is a research peptide in the glp-1 / weight management category. Cagrilintide is a long-acting amylin receptor agonist that mimics the satiety effects of the pancreatic hormone amylin. MiPeptidos offers Cagrilintide in 2 sizes with 99.8% verified purity and full analytical documentation.
How Cagrilintide Works
Cagrilintide is a long-acting amylin receptor agonist that mimics the satiety effects of the pancreatic hormone amylin. It activates amylin receptors (AMY1 and AMY3) and calcitonin receptors in the area postrema and nucleus tractus solitarius of the brainstem, reducing appetite and food intake. The C20 fatty acid modification enables albumin binding for extended duration of action. It is being developed in combination with semaglutide (CagriSema) for enhanced weight loss.
Research Applications
Pricing
| Size | Per Vial | 10-Pack |
|---|---|---|
5mg | $51.95 | $378.95 |
10mgBest Value | $92.95 | $678.95 |
Prices shown per vial from 10-pack. Volume discounts available for 50+ vials — contact us.
HPLC Purity Analysis
Certificate of Analysis
This COA is a representative sample. A batch-specific Certificate of Analysis with full HPLC chromatograms and mass spectrometry data is included with every MiPeptidos order.
Reconstitution Calculator
Inject bacteriostatic water slowly along the vial wall. Gently swirl until dissolved — never shake. Store reconstituted solution at 2-8°C and use within 30 days.
Download Product Brochure
Get our detailed Cagrilintide product brochure with specifications, research applications, HPLC analysis data, and reconstitution guide. Available in English and Spanish.
Customer Reviews
Frequently Asked Questions
Specifications
Sequence
37-amino acid long-acting amylin analog with Cys2-Cys7 disulfide bridge, Pro25/Pro28/Pro29 mutations, and N-terminal C20 fatty diacid (eicosanedioic acid) conjugation via gamma-Glu linker
Research Use Only. This product is intended for laboratory research purposes only. Not for human consumption. Handle with appropriate safety precautions.
Related Peptides

Semaglutide
A glucagon-like peptide-1 (GLP-1) receptor agonist originally developed for glycemic control. Widely studied for its role in appetite regulation and metabolic research.

Tirzepatide
A dual GIP/GLP-1 receptor agonist studied for its effects on glucose metabolism and body weight regulation. One of the most researched peptides in the incretin class.

Retatrutide
A triple agonist targeting GIP, GLP-1, and glucagon receptors. Investigated in preclinical and clinical research for its multi-pathway approach to metabolic regulation.

Liraglutide
A GLP-1 receptor agonist with an extended half-life due to fatty acid acylation. Extensively studied for glucose homeostasis and appetite signaling research.